Stay updated on Talimogene & Pembrolizumab Combo in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Talimogene & Pembrolizumab Combo in Melanoma Clinical Trial page.

Latest updates to the Talimogene & Pembrolizumab Combo in Melanoma Clinical Trial page
- ChecktodayChange DetectedThe history shows a new Revision: v3.6.2 replacing Revision: v3.6.0. This indicates a newer revision entry has been posted for the study record.SummaryDifference0.1%

- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe history now indicates the study is no longer looking for participants, clarifying enrollment status. A new record revision v3.6.0 was added and the previous revision v3.5.5 was removed, reflecting an updated version of the study record.SummaryDifference0.3%

- Check22 days agoChange DetectedAdded a new revision entry: v3.5.5. Removed the previous revision entry: v3.5.4.SummaryDifference0.1%

- Check43 days agoChange DetectedA new revision entry v3.5.4 was added to the Record History. The previous revision v3.5.3 was removed.SummaryDifference0.1%

- Check57 days agoChange DetectedA new revision entry (v3.5.3) was added to the study's history, replacing the previous revision (v3.5.2) and signaling an updated posting date for the record.SummaryDifference0.1%

- Check72 days agoChange DetectedRevision: v3.5.2 was added, replacing v3.5.0. This appears to be a system update and does not change the study history data shown on the page.SummaryDifference0.1%

Stay in the know with updates to Talimogene & Pembrolizumab Combo in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Talimogene & Pembrolizumab Combo in Melanoma Clinical Trial page.